Consistent with the above assumption, we found PPT1 have special prognostic value in the first subtype, and knockdown of PPT1 significantly neutralized the PKM2 overexpression-induced growth advantage in HCC cells. This evidence concerns the gene PKM and hepatocellular carcinoma.